International Journal of Antimicrobial Agents

Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants
pp. 411-417(7)
Authors: Amaral L.; Kristiansen J.E.

Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes
pp. 419-425(7)
Authors: Hand W.L.; Hand D.L.

Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases
pp. 427-431(5)
Authors: Treadway G.; Reisman A.

Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates
pp. 433-436(4)
Authors: Schmitz F.-J.; Perdikouli M.; Beeck A.; Verhoef J.; Fluit A.C.

Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods
pp. 437-440(4)
Authors: Deshpande L.; Biedenbach D.J.; Jones R.N.

Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid
pp. 441-444(4)
Authors: Sambatakou H.; Giamarellos-Bourboulis E.J.; Galanakis N.; Giamarellou H.

In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid
pp. 445-447(3)
Authors: Tunger O.; Arisoy A.; Kurutepe S.; Akcali S.; Ozbakkaloglu B.

AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity
pp. 451-461(11)
Authors: Mori N.; Kodama T.; Sakai A.; Suzuki T.; Sugihara T.; Yamaguchi S.; Nishijima T.; Aoki A.; Toriya M.; Kasai M.; Hatano S.; Kitagawa M.; Yoshimi A.; Nishimura K.-i.

Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil
pp. 463-469(7)
Authors: Totsuka K.; Shimizu K.; Mori N.; Sugihara T.; Sakai A.; Yamaji S.; Michisuji Y.; Shinohara Y.; Kubo A.; Tokuoka H.

Effects of the quantity of water and milk ingested concomitantly with AS-924, a novel ester-type cephem antibiotic, on its pharmacokinetics
pp. 471-476(6)
Authors: Matsumoto F.; Sakurai I.; Morita M.; Takahashi T.; Mori N.; Sugihara T.; Sakai A.; Yamaji S.; Akaike Y.; Yano K.

Effect of antacid pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic-comparison with cefteram-pivoxil
pp. 477-482(6)
Authors: Totsuka K.; Shimizu K.; Mori N.; Sugihara T.; Sakai A.; Yamaji S.; Michisuji Y.; Shinohara Y.; Kubo A.; Tokuoka H.

Effects of gastrointestinal stimulant and suppressant pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic
pp. 483-487(5)
Authors: Yanagawa A.; Shimada J.; Mori N.; Sugihara T.; Sakai A.; Yamaji S.; Yano K.; Kitamura T.; Kano T.

Pharmacokinetics of cefcapene pivoxil and AS-924 in gastrectomized patients
pp. 489-494(6)
Author: Fujimoto M.